Skip to content

Effect of EC-IC bypass surgery in the acute stage of atherothrombotic infarction in the territory of the carotid artery; a randomized clinical trial

Effect of EC-IC bypass surgery in the acute stage of atherothrombotic infarction in the territory of the carotid artery; a randomized clinical trial - Acute bypass study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001895
Enrollment
80
Registered
2009-05-01
Start date
2009-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

Bypass surgery immediately following second step of the registration Medical therapy following second step of the registration. If there is a further aggravation by 3 points in NIHSS, bypass surgery w

Sponsors

Department of Neurosurgery, Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: First step:1)age 20-75, 2)within 72 hours after the onset, 3) independent before the onset, 4) DWI-ASPECTS>or=8 and presence of diffusion/perfusion mismatch or clinical/diffusion mismatch. Second step: Neurological deteriolation by 1-3 points in NIHSS scale (due to aggravetion of infarction or penumbra, but not edema or hemorrhagic infarction) following the first step. The vascular lesion must be out of indication of endovascular surgery or carotid endarterectomy.

Exclusion criteria

Exclusion criteria: First step:1)preexisting ipsilateral cerebral infarction larger than 1/3 of the hemisphere, 2)candidates for endovascular surgery or carotid endarterectomy, 3) non-atherothrombotic lesion or cardioembolic infarction, 4) Association of severe general condition such as malignant tumors, renal/cardiac/liver/lung failure etc., 5) acute myocardial infarction within 6 months, 6) severe arythmia or ischemic changes on electrocardiogram. Second step: 1) edema or hemorhagic infarction that can acount for the clinical deteriolation, 2) aggravation in the general condition

Design outcomes

Primary

MeasureTime frame
Proportion of mRS 0-2 (good outcome) at 3 month after the second registration. *patients who were in the waiting group and finally operated will be counted as bad outcome regardless of mRS at 3 month

Secondary

MeasureTime frame
Effectiveness a) Proportion of mRS 0-2 (good outcome) at 1 month after the second registration. *patients who were in the waiting group and finally operated will be counted as bad outcome regardless of mRS at 1 month b) Proportion of mRS 0-1 at 3 month after the second registration. *patients who were in the waiting group and finally operated will be counted as bad outcome regardless of mRS at 3 month c) Proportion of patients with enlargement or recurrence of ipsilateral infarction within 1 month after the second registration. *patients who were in the waiting group and finally operated will be counted as enlargement regardless of imaging findings. d) Evaluation of mRS at 3 month after the first registration in patients who were not included in the second registration; comparison between patients enrolled by using criteria of diffusion/perfusion mismatch and clinical/diffusion mismatch. Safety a) Rate of general complications which required elongation of hospital stay.*patients who were in the waiting group and finally operated will also be evaluated.

Countries

Japan

Contacts

Public ContactHiroaki Shimizu

Akita University Graduate School of Medicine Department of Neurosurgery

hshim@nsg.med.akita-u.ac.jp018-884-6140

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026